Abstract
Robert Rosenson has received honoraria from Amgen, Kowa, Pfizer, and Regeneron; consultancy/advisory board fees from Amgen, C5, Corvidia, CVS Caremark, Medicines Company, and Regeneron; and research funding from Akcea, Amgen, AstraZeneca, Medicines Compan.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
